Accu-Chek Aviva Plus System
System, Test, Blood Glucose, Over The Counter. 510(k) K133862, from Roche Diagnostics Corporation (Indianapolis, IN). Product code NBW, class 2.
As of Nov 18, 2026, K133862 is an FDA 510(k) held by Roche Diagnostics Corporation, substantially equivalent on Apr 29, 2014 after 131 days, with 2 recalls tied to it in FDA's recall database.
- Substantially equivalent: Apr 29, 2014
- Review time: 131 days
- Recalls: 2
- Cited as a predicate by: 1 device
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe ACCU-CHEK Aviva Plus Blood Glucose Monitoring System is intended to be used for the quantitative measurement of glucose (sugar) in fresh capillary whole blood samples drawn from the fingertips, forearm, upper arm, or palm. The ACCU-CHEK Aviva Plus Blood Glucose Monitoring System is intended to be used by a single person and should not be shared.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- Accu-Chek Aviva Plus Blood Glucose Monitoring SystemK101299 · Roche Diagnostics · Sep 21, 2011
Cited as a Predicate
1 later 510(k) summary names this device as a predicate- Accu-Chek Aviva Connect Blood Glucose Monitoring SystemK141867 · Roche Diagnostics · Mar 3, 2015
Recalls
Recalls FDA ties to K133862, newest first; each opens FDA's recall record| Jun 12, 2017 | Z-2765-2019Meters may contain a damaged C29 capacitor resulting in issues with power allegation (short battery life or meter not turning on). | Terminated |
| Jun 12, 2017 | Z-2766-2019Meters may contain a damaged C29 capacitor resulting in issues with power allegation (short battery life or meter not turning on). | Terminated |
Other NBW Clearances
The newest 510(k)s for the same product code; their median review was 213 days; see every NBW device- Safe AQ Easy Blood Glucose Monitoring System; Safe AQ Care Blood Glucose Monitoring SystemK260738 · Changsha Sinocare, Inc. · Oct 30, 2026
- EASYMAX Voice Blood Glucose Monitoring SystemK261293 · EPS Bio Technology Corp. · Oct 23, 2026
- VivaChek Blood Glucose and ß-Ketone Dual BLE Monitoring System;VivaChek Blood Glucose and ß-Ketone Dual Monitoring…K260687 · Vivachek Biotech (Hangzhou) Co., Ltd. · Oct 9, 2026
- CVS Advanced PLUS Blood Glucose Monitoring SystemK260689 · I-Sens, Inc. · Oct 2, 2026
- CONTOUR® PLUS BLUE Blood Glucose Monitoring System; CONTOUR® NEXT GEN Blood Glucose Monitoring System; CONTOUR® NEXT…K260545 · Ascensia Diabetes Care · Aug 27, 2026
- TRUE METRIX Self Monitoring Blood Glucose SystemK262116 · Trividia Health, Inc. · Jul 23, 2026
- On Call® Sure GK Blood Glucose & Ketone Monitoring System; On Call® Sure Sync GK Blood Glucose & Ketone Monitoring…K250085 · ACON Laboratories, Inc. · Oct 10, 2025
- TeleRPM Gen2 Blood Glucose Monitoring SystemK243060 · Guangdong Transtek Medical Electronics Co., Ltd. · Jan 30, 2025
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Dec 19, 2013
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1345
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files